AAAAAA

   
Results: 1-25 | 26-42 |
Results: 26-42/42
Effect of amino acids on the plasma concentration and urinary excretion ofuric acid and uridine
Authors: Yamamoto, T Moriwaki, Y Takahashi, S Tsutsumi, Z Ohata, H Yamakita, J Nakamo, T Higashino, K
Citation: T. Yamamoto et al., Effect of amino acids on the plasma concentration and urinary excretion ofuric acid and uridine, METABOLISM, 48(8), 1999, pp. 1023-1027
Effects of fructose and xylitol on the urinary excretion of adenosine, uridine, and purine bases
Authors: Yamamoto, T Moriwaki, Y Takahashi, S Tsutsumi, Z Yamakita, J Higashino, K
Citation: T. Yamamoto et al., Effects of fructose and xylitol on the urinary excretion of adenosine, uridine, and purine bases, METABOLISM, 48(4), 1999, pp. 520-524
Effect of glucose on the plasma concentration and urinary excretion of uridine and purine bases
Authors: Yamamoto, T Moriwaki, Y Takahashi, S Tsutsumi, Z Yamakita, J Nakano, T Higashino, K
Citation: T. Yamamoto et al., Effect of glucose on the plasma concentration and urinary excretion of uridine and purine bases, METABOLISM, 48(3), 1999, pp. 338-341
Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens
Authors: Hayashi, N Matsui, K Tsutsui, H Osada, Y Mohamed, RT Nakano, H Kashiwamura, S Hyodo, Y Takeda, K Akira, S Hada, T Higashino, K Kojima, S Nakanishi, K
Citation: N. Hayashi et al., Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens, J IMMUNOL, 163(12), 1999, pp. 6702-6711
IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor
Authors: Hyodo, Y Matsui, K Hayashi, N Tsutsui, H Kashiwamura, S Yamauchi, H Hiroishi, K Takeda, K Tagawa, Y Iwakura, Y Kayagaki, N Kurimoto, M Okamura, H Hada, T Yagita, H Akira, S Nakanishi, K Higashino, K
Citation: Y. Hyodo et al., IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor, J IMMUNOL, 162(3), 1999, pp. 1662-1668
Direct numerical simulation of oscillatory Marangoni convection, in cylindrical liquid bridges
Authors: Zeng, Z Mizuseki, H Higashino, K Kawazoe, Y
Citation: Z. Zeng et al., Direct numerical simulation of oscillatory Marangoni convection, in cylindrical liquid bridges, J CRYST GR, 204(3), 1999, pp. 395-404
Purified group X secretory phospholipase A(2) induced prominent release ofarachidonic acid from human myeloid leukemia cells
Authors: Hanasaki, K Ono, T Saiga, A Morioka, Y Ikeda, M Kawamoto, K Higashino, K Nakano, K Yamada, K Ishizaki, J Arita, H
Citation: K. Hanasaki et al., Purified group X secretory phospholipase A(2) induced prominent release ofarachidonic acid from human myeloid leukemia cells, J BIOL CHEM, 274(48), 1999, pp. 34203-34211
Different functional aspects of the group II subfamily (types IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostaglandin generation - Implications of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation
Authors: Murakami, M Kambe, T Shimbara, S Higashino, K Hanasaki, K Arita, H Horiguchi, M Arita, M Arai, H Inoue, K Kudo, I
Citation: M. Murakami et al., Different functional aspects of the group II subfamily (types IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostaglandin generation - Implications of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation, J BIOL CHEM, 274(44), 1999, pp. 31435-31444
Cloning and characterization of novel mouse and human secretory phospholipase A(2)s
Authors: Ishizaki, J Suzuki, N Higashino, K Yokota, Y Ono, T Kawamoto, K Fujii, N Arita, H Hanasaki, K
Citation: J. Ishizaki et al., Cloning and characterization of novel mouse and human secretory phospholipase A(2)s, J BIOL CHEM, 274(35), 1999, pp. 24973-24979
Plasma levels of pipecolic acid, both L- and D-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy
Authors: Fujita, T Amuro, Y Hada, T Higashino, K
Citation: T. Fujita et al., Plasma levels of pipecolic acid, both L- and D-enantiomers, in patients with chronic liver diseases, especially hepatic encephalopathy, CLIN CHIM A, 287(1-2), 1999, pp. 99-109
Origin of D- and L-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test
Authors: Fujita, T Hada, T Higashino, K
Citation: T. Fujita et al., Origin of D- and L-pipecolic acid in human physiological fluids: a study of the catabolic mechanism to pipecolic acid using the lysine loading test, CLIN CHIM A, 287(1-2), 1999, pp. 145-156
A case of classical xanthinuria (type 1) with diabetes mellitus and Hashimoto's thyroiditis
Authors: Shibutani, Y Ueo, T Yamamoto, T Takahashi, S Moriwaki, Y Higashino, K
Citation: Y. Shibutani et al., A case of classical xanthinuria (type 1) with diabetes mellitus and Hashimoto's thyroiditis, CLIN CHIM A, 285(1-2), 1999, pp. 183-189
Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein
Authors: Hada, T Kondo, M Yasukawa, K Amuro, Y Higashino, K
Citation: T. Hada et al., Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein, CLIN CHIM A, 281(1-2), 1999, pp. 37-46
Cisplatin in combination with irinotecan in the treatment of patients withmalignant pleural mesothelioma - A pilot phase II clinical trial and pharmacokinetic profile
Authors: Nakano, T Chahinian, AP Shinjo, M Togawa, N Tonomura, A Miyake, M Ninomiya, K Yamamoto, T Higashino, K
Citation: T. Nakano et al., Cisplatin in combination with irinotecan in the treatment of patients withmalignant pleural mesothelioma - A pilot phase II clinical trial and pharmacokinetic profile, CANCER, 85(11), 1999, pp. 2375-2384
'Pseudohypouricosuria' in alcaptonuria: homogentisic acid interference in the measurement of urinary uric acid with the uricase-peroxidase reaction
Authors: Moriwaki, Y Yamamoto, T Nasako, Y Ohata, H Takahashi, S Tsutsumi, Z Yamakita, J Higashino, K
Citation: Y. Moriwaki et al., 'Pseudohypouricosuria' in alcaptonuria: homogentisic acid interference in the measurement of urinary uric acid with the uricase-peroxidase reaction, ANN CLIN BI, 36, 1999, pp. 501-503
High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient
Authors: Yamamoto, T Moriwaki, Y Matsui, K Takahashi, S Tsutsui, H Yoshimoto, T Okamura, H Nakanishi, K Kurosawa, Y Yamaguchi, S Sasaki, Y Higashino, K
Citation: T. Yamamoto et al., High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient, ARCH DIS CH, 81(2), 1999, pp. 179-180
Determination of adenosine and deoxyadenosine in urine by high-performanceliquid chromatography with column switching
Authors: Yamamoto, T Moriwaki, Y Takahashi, S Fujita, T Tsutsumi, Z Yamakita, J Shimizu, K Shioda, M Ohta, S Higashino, K
Citation: T. Yamamoto et al., Determination of adenosine and deoxyadenosine in urine by high-performanceliquid chromatography with column switching, J CHROMAT B, 719(1-2), 1998, pp. 55-61
Risultati: 1-25 | 26-42 |